Purpose: To investigate the frequency, influence of arterial phase timing and risk factors for TSM artifacts in arterial phase of gadoxetate-enhanced MRI of the liver. Materials and Methods: Between 2013-2016, gadoxetate-enhanced liver MRI of 354 patients (196 men, 158 women, mean age 60.8±14.2 years) were retrospectively enrolled. Sixty-nine patients received follow-up. Arterial phase images were evaluated regarding motion artifacts on a four-point scale (0 = no motion artifacts, 1 = minor artifacts, 2 = distinct artifacts, 3 = severe artifacts/non-diagnostic). Occurrence and artifact grading were correlated with arterial phase timing (early, true and late arterial phase), previous TSM and selected risk factors such as patients' demographics, behaviors and laboratory data. Results: TSM artifacts occurred in 48.6% (172/354) of the patients. 25.7%
Introduction
Contrast-enhanced magnetic resonance imaging (MRI) is a clinically established imaging modality for visualizing and characterizing focal lesions in the liver [1] [2] [3] [4] . Especially gadoxetate disodium (Primovist®, Eovist®, Bayer-Schering Healthcare), a gadolinium-based hepatobiliary contrast agent, has proven to be of very high diagnostic value to assess hepatobiliary diseases since its approval [4] [5] [6] [7] [8] .
However, according to recent studies intravenous bolus injection of gadoxetate disodium is also associated with the occurrence of acute transient dyspnea accompanied by transient severe motion (TSM) artifacts in the arterial phase [9, 10] . This phenomenon is experienced by patients as temporary and self-limited (or "transient") and does not occur after the hepatic arterial phase. As, however, the arterial phase is essential for the characterization of focal lesions [11] , TSM leads to image degradation and reduced diagnostic accuracy and therefore proves to be of high clinical importance. Compared to the application of the alternative contrast agent gadobenate dimeglumine, the incidence of TSM in patients receiving gadoxetate disodium was found to be significantly higher with 11-22% vs 0.5-2% [9, 10, 12] . The underlying mechanism, however, is not yet solved.
Until now, the incidence of TSM has been linked to chronic obstructive pulmonary disease (COPD), volume of gadoxetate administration, body mass index, male sex and prior episode of arterial phase motion in MR examination [7, 9, 10, [12] [13] [14] . However, at this time the causation of TSM after administration of gadoxetate disodium is not yet definitely clarified. In our opinion, acute transient dyspnea in gadoxetate-enhanced liver MRI as a reason for motion artifacts is of high clinical importance, since image degradation could impair diagnostic quality. Therefore, the purpose of our study was to investigate the influence of image acquisition parameters, such as arterial phase timing and patient characteristics on the frequency and severity of TSM.
Materials and Methods
The retrospective study was approved by the local ethics committee of the XXX (BB 113/16). The requirement to obtain informed consent of the participants was waived.
Data were assessed anonymously.
Study Population
The An overview of the study design is presented in a flow chart ( Figure 1 ). 
Statistics
All descriptive data were described as absolute numbers 
Results

Interobserver reliability
The interobserver agreement with regard to the presence of TSM artifacts was good with Kappa=0.696 (standard error 0.0482).
Occurrence and graduation of transient severe motion artifacts (TSM)
Transient severe motion artifacts were detected in 48.6% of the examinations (n=172). Most patients had minor artifacts with a motion score of 1 (22.9%, n=81). 18.4% (n=65) of the patients showed distinct artifacts (motion score 2) and 7.3% (n=26) severe artifacts (motion score 3). with arterial phase timing (p = 0.031; p = 0.012).
Risk factor analysis
The occurrence and severity of TSM were analyzed with regard to underlying potential risk factors ( 
Influence of prior TSM
Discussion
Our study investigates the occurrence of transient severe 
Conclusion
In First aim has, therefore, to be the reduction of such artifactrelated image degradation to guarantee adequate image evaluation.
